跳至主要内容
临床试验/NCT05249894
NCT05249894Unknown不适用

Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of Sepsis Scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient With Acute Myeloid Leukemia Treated With Intensive Chemotherapy (LAM-SEPSIS)

A.O.U. Città della Salute e della Scienza1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2022年3月23日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
400
试验地点
1
主要终点
Mortality risk

研究概览

简要总结

Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of sepsis scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient With Acute Myeloid Leukemia Treated With Intensive Chemotherapy

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of non M3 Acute Myeloid Leukemia according to WHO (World Health Organization) 2008 criteria
  • Age >= 18 years and <= 70 years
  • Patient had received intensive chemotherapy either as induction or consolidation regimen
  • Period of observation: January 2001 - December 2019
  • Written informed consent

排除标准

  • Diagnosis of Acute Promyelocytic Leukemia (M3 AML)
  • Age < 18 or >70 years
  • Patient had not received intensive chemotherapy

结局指标

主要结局

Mortality risk

时间窗: At baseline (fever onset), change at 24 hours from baseline, change at 48 hours from baseline

Ability of NEWS and qSOFA score to predict mortality risk calculating the area under the ROC (receiver operating characteristics) curve called AUROC (area under the ROC curve)

次要结局

  • Bloodstream infections(From date of fever onset until the date of fever resolution, assessed up to 60 days)
  • Systemic Inflammatory Response Syndrome (SIRS) development(At baseline (fever onset), change at 24 hours from baseline, change at 48 hours from baseline)
  • Intensive care unit (ICU) admission(At baseline (fever onset), change at 24 hours from baseline, change at 48 hours from baseline)
  • Amine requirement(At baseline (fever onset), change at 24 hours from baseline, change at 48 hours from baseline)
  • Respiratory failure(At baseline (fever onset), change at 24 hours from baseline, change at 48 hours from baseline)
  • Ventilation support(At baseline (fever onset), change at 24 hours from baseline, change at 48 hours from baseline)
  • Number of infections(From date of neutrophils count <500/mmc until the day of neutrophils count >=500/mmc, assessed up to 60 days)

研究者

发起方
A.O.U. Città della Salute e della Scienza
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chiara Frairia

Medical Doctor in Hematology

A.O.U. Città della Salute e della Scienza

研究点 (1)

Loading locations...

相似试验

Evaluation of Infective Risk, Efficacy of Bacterial... | 临床试验